COTQF
Price:
$0.0001
Market Cap:
$2.20K
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharma...[Read more]
Industry
Biotechnology
IPO Date
2009-09-28
Stock Exchange
OTC
Ticker
COTQF
According to Cotinga Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.88% compared to the average of -0.10 of the last 4 quarters.
The mean historical PE Ratio of Cotinga Pharmaceuticals Inc. over the last ten years is -0.59. The current -0.00 PE Ratio has changed -98.02% with respect to the historical average. Over the past ten years (40 quarters), COTQF's PE Ratio was at its highest in in the April 2019 quarter at -0.06. The PE Ratio was at its lowest in in the October 2016 quarter at -2.66.
Average
-0.59
Median
-0.58
Minimum
-1.25
Maximum
-0.08
Discovering the peaks and valleys of Cotinga Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.52%
Maximum Annual PE Ratio = -0.08
Minimum Annual Increase = -84.87%
Minimum Annual PE Ratio = -1.25
| Year | PE Ratio | Change |
|---|---|---|
| 2019 | -0.08 | -43.60% |
| 2018 | -0.14 | -84.87% |
| 2017 | -0.94 | -24.94% |
| 2016 | -1.25 | 81.52% |
| 2015 | -0.69 | 18.14% |
| 2014 | -0.58 | 36.91% |
The current PE Ratio of Cotinga Pharmaceuticals Inc. (COTQF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.39
5-year avg
-0.62
10-year avg
-0.59
Cotinga Pharmaceuticals Inc.’s PE Ratio is less than ForU Holdings, Inc. (-0.00), greater than Regnum Corp. (-0.00), greater than OncoVista Innovative Therapies, Inc. (-0.00), less than iBX Group, Inc. (0), less than Anthera Pharmaceuticals, Inc. (-0.00), less than 9 Meters Biopharma, Inc. (0), greater than Dermisonics, Inc. (-0.00), greater than Fiore Cannabis Ltd. (-0.00), greater than Urologix, Inc. (-0.00), less than Optigenex Inc. (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $2.17K | |
| -0.00 | $2.29K | |
| -0.00 | $2.36K | |
| 0 | $1.98K | |
| -0.00 | $2.62K | |
| 0 | $1.45K | |
| -0.00 | $1.92K | |
| -0.00 | $1.97K | |
| -0.00 | $2.18K | |
| 0 | $11.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cotinga Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cotinga Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cotinga Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Cotinga Pharmaceuticals Inc. (COTQF)?
What is the highest PE Ratio for Cotinga Pharmaceuticals Inc. (COTQF)?
What is the 3-year average PE Ratio for Cotinga Pharmaceuticals Inc. (COTQF)?
What is the 5-year average PE Ratio for Cotinga Pharmaceuticals Inc. (COTQF)?
How does the current PE Ratio for Cotinga Pharmaceuticals Inc. (COTQF) compare to its historical average?